The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug and chemical safety assessments. The FDA has released draft guidance ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...

Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...

Sponsors will now be able to submit preclinical toxicology data using virtual animal controls instead of a standard animal ...

Britain's medicines regulator said on Wednesday it will introduce a framework by the end of ​2026, which would allow ...

Add Yahoo as a preferred source to see more of our stories on Google. Martin Makary, President Donald Trump's nominee to lead the Food and Drug Administration testifies during his confirmation hearing ...

A group of scientists from a biotechnology startup known as R3 Bio have created multi-organ biological platforms know as ...

The U.S. Food and Drug Administration said on Thursday that it will be phasing out the animal testing requirement for monoclonal antibody therapies and other drugs, replacing it with more ethical ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

Recursion Pharmaceuticals' stock has been volatile, and is soaring today on news the FDA is planning on phasing out some animal testing, replacing it with AI. The company's Q4 FY24 earnings showed ...